BIOSPECIFICS TECHNOLOGIES CORP Deferred Tax Assets, Valuation Allowance
BIOSPECIFICS TECHNOLOGIES CORP had Deferred Tax Assets, Valuation Allowance of $0 as of 2013-12-31, per its 10-K filed 2014-03-07.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2014-03-07
- 2013-12-31: Deferred Tax Assets, Valuation Allowance $0.00.
- 2012-12-31: Deferred Tax Assets, Valuation Allowance $0.00.
- 2011-12-31: Deferred Tax Assets, Valuation Allowance $0.00.
- 2010-12-31: Deferred Tax Assets, Valuation Allowance $3.60M; Deferred Tax Assets, Valuation Allowance as first filed $3.60M.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2013-12-31 | $0.00 10-K · filed 2014-03-07 | |
| 2012-12-31 | $0.00 10-K · filed 2014-03-07 | |
| 2011-12-31 | $0.00 10-K · filed 2014-03-07 | |
| 2010-12-31 | $3.60M 10-K · filed 2014-03-07 | $3.60M 10-K · filed 2013-03-15 |